Quarterly report pursuant to Section 13 or 15(d)

Schedule of Warrant Activities (Details)

v3.23.2
Schedule of Warrant Activities (Details) - Warrant [Member] - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Number of Shares, Balance 7,083,500
Weighted Average Exercise Price, Balance $ 0.05
Aggregate Intrinsic Value [1] $ 850
Number of Shares, Granted   7,083,500
Weighted Average Exercise Price, Granted   $ 0.05
Number of Shares, Balance   7,083,500
Weighted Average Exercise Price, Balance   $ 0.05
Weighted Average Remaining Contractual Term in Years   4 years 3 months 18 days
Aggregate Intrinsic Value [1]   $ 850
Exercisable, Balance 7,083,500  
Weighted Average Exercise Price, Exercisable $ 0.05  
Weighted Average Remaining Contractual Term in Years, Exercisable 4 years 1 month 6 days  
Aggregate Intrinsic Value, Exercisable [1] $ 991  
[1] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $ 0.1899 for our common stock on March 31, 2023.